1 Godart, NT, Flament, MF, Lecrubier, Y, Jeammet, P. Anxiety disorders in anorexia nervosa and bulimia nervosa: co‐morbidity and chronology of appearance. Eur Psychiatry 2000, 15:38–45.
2 Casper, RC. Depression and eating disorders. Depress Anxiety 1998, 8(Suppl 1):96–104.
3 Jean, A, Conductier, G, Manrique, C, Bouras, C, Berta, P, Hen, R, Charnay, Y, Bockaert, J, Compan, V. Anorexia induced by activation of serotonin 5‐HT4 receptors is mediated by increases in CART in the nucleus accumbens. Proc Natl Acad Sci U S A 2007, 104:16335–16340.
4 Sullivan, PF. Mortality in anorexia nervosa. Am J Psychiatry 1995, 152:1073–1074.
5 Signorini, A, De Filippo, E, Panico, S, De Caprio, C, Pasanisi, F, Contaldo, F. Long‐term mortality in anorexia nervosa: a report after an 8‐year follow‐up and a review of the most recent literature. Eur J Clin Nutr 2007, 61:119–122.
6 Compan, V. %22Do limits of neuronal plasticity represent an opportunity for mental diseases, such as addiction to food and illegal drugs? Use and utilities of serotonin receptor knock‐out mice.%22 In: Chattopadhyay, A, ed. Serotonin Receptors in Neurobiology. Boca Raton, FL: CRC Press, New Frontiers in Neurosciences
; 2007, 157–180.
7 Lucas, JJ, Yamamoto, A, Scearce‐Levie, K, Saudou, F, Hen, R. Absence of fenfluramine‐induced anorexia and reduced c‐Fos induction in the hypothalamus and central amygdaloid complex of serotonin 1B receptor knock‐out mice. J Neurosci 1998, 18:5537–5544.
8 Vickers, SP, Clifton, PG, Dourish, CT, Tecott, LH. Reduced satiating effect of d‐fenfluramine in serotonin 5‐HT(2C) receptor mutant mice. Psychopharmacology (Berl) 1999, 143:309–314.
9 Frith, CH, Chang, LW, Lattin, DL, Walls, RC, Hamm, J, Doblin, R. Toxicity of methylenedioxymethamphetamine (MDMA) in the dog and the rat. Fundam Appl Toxicol 1987, 9:110–119.
10 Rochester, JA, Kirchner, JT. Ecstasy (3,4‐methylenedioxymethamphetamine): history, neurochemistry, and toxicology. J Am Board Fam Pract 1999, 12: 137–142.
11 Conductier, G, Crosson, C, Hen, R, Bockaert, J, Compan, V. 3,4‐N‐methlenedioxymethamphetamine‐induced hypophagia is maintained in 5‐HT1B receptor knockout mice, but suppressed by the 5‐HT2C receptor antagonist RS102221. Neuropsychopharmacology 2005, 30:1056–1063.
12 Ramboz, S, Oosting, R, Amara, DA, Kung, HF, Blier, P, Mendelsohn, M, Mann, JJ, Brunner, D, Hen, R. Serotonin receptor 1A knockout: an animal model of anxiety‐related disorder. Proc Natl Acad Sci U S A 1998, 95:14476–14481.
13 Saudou, F, Amara, DA, Dierich, A, LeMeur, M, Ramboz, S, Segu, L, Buhot, MC, Hen, R. Enhanced aggressive behavior in mice lacking 5‐HT1B receptor. Science 1994, 265:1875–1878.
14 Weisstaub, NV, Zhou, M, Lira, A, Lambe, E, Gonzalez‐Maseo, J, Hornung, JP, Sibille, E, Underwood, M, Itohara, S, Dauer, WT, et al. Cortical 5‐HT2A receptor signaling modulates anxiety‐like behaviors in mice. Science 2006, 313:536–540.
15 Nebigil, CG, Choi, DS, Dierich, A, Hickel, P, Le Meur, M, Messaddeq, N, Launay, JM, Maroteaux, L. Serotonin 2B receptor is required for heart development. Proc Natl Acad Sci U S A 2000, 97:9508–9513.
16 Tecott, LH, Sun, LM, Akana, SF, Strack, AM, Lowenstein, DH, Dallman, MF, Julius, D. Eating disorder and epilepsy in mice lacking 5‐HT2c serotonin receptors. Nature 1995, 374:542–546.
17 Zeitz, KP, Guy, N, Malmberg, AB, Dirajlal, S, Martin, WJ, Sun, L, Bonhaus, DW, Stucky, CL, Julius, D, Basbaum, AI. The 5‐HT3 subtype of serotonin receptor contributes to nociceptive processing via a novel subset of myelinated and unmyelinated nociceptors. J Neurosci 2002, 22:1010–1019.
18 Compan, V, Zhou, M, Grailhe, R, Gazzara, RA, Martin, R, Gringrich, J, Dumuis, A, Brunner, D, Bockaert, J, Hen, R. Attenuated response to stress and novelty and hypersensitivity to seizures in 5‐HT4 receptor knock‐out mice. J Neurosci 2004, 24:412–419.
19 Wagner, A, Aizenstein, H, Venkatraman, VK, Bischoff‐Grethe, A, Fudge, J, May, JC, Franc, GK, Bailer, UF, Fischer, L, Putnam, K, et al. Altered striatal response to reward in bulimia nervosa after recovery. Int J Eat Disord 2010, 43:289–294.
20 Bockaert, J, Claeysen, S, Becamel, C, Dumuis, A, Marin, P. Neuronal 5‐HT metabotropic receptors: fine‐tuning of their structure, signaling, and roles in synaptic modulation. Cell Tissue Res 2006, 326:553–572.
21 Parks, CL, Robinson, PS, Sibille, E, Shenk, T, Toth, M. Increased anxiety of mice lacking the serotonin1A receptor. Proc Natl Acad Sci U S A 1998, 95: 10734–10739.
22 Dirks, A, Pattij, T, Bouwknecht, JA, Westphal, TT, Hijzen, TH, Groenink, L, Van der Gugten, J, Oosting, RS, Hen, R, Geyer, MA, et al. 5‐HT1B receptor knockout, but not 5‐HT1A receptor knockout mice, show reduced startle reactivity and footshock‐induced sensitization, as measured with the acoustic startle response. Behav Brain Res 2001, 118:169–178.
23 Dulawa, SC, Gross, C, Stark, KL, Hen, R, Geyer, MA. Knockout mice reveal opposite roles for serotonin 1A and 1B receptors in prepulse inhibition. Neuropsychopharmacology 2000, 22:650–659.
24 Gross, C, Zhuang, X, Stark, K, Ramboz, S, Oosting, R, Kirby, L, Santarelli, L, Beck, S, Hen, R. Serotonin1A receptor acts during development to establish normal anxiety‐like behaviour in the adult. Nature 2002, 416:396–400.
25 Zhuang, X, Gross, C, Santarelli, L, Compan, V, Trillat, AC, Hen, R. Altered emotional states in knockout mice lacking 5‐HT1A or 5‐HT1B receptors. Neuropsychopharmacology 1999, 21:52S–60S.
26 Bouwknecht, JA, Van der Gugten, J, Hijzen, TH, Maes, RA, Hen, R, Olivier, B. Male and female 5‐HT(1B) receptor knockout mice have higher body weights than wildtypes. Physiol Behav 2001, 74:507–516.
27 Brunner, D, Buhot, MC, Hen, R, Hofer, M. Anxiety, motor activation, and maternal‐infant interactions in 5HT1B knockout mice. Behav Neurosci 1999, 113:587–601.
28 Conductier, G, Dusticier, N, Lucas, G, Cote, F, Debonnel, G, Daszuta, A, Dumuis, A, Nieoullon, A, Hen, R, Bockaert, J, et al. Adaptive changes in serotonin neurons of the raphe nuclei in 5‐HT(4) receptor knock‐out mouse. Eur J Neurosci 2006, 24:1053–1062.
29 Dulawa, SC, Hen, R, Scearce‐Levie, K, Geyer, MA. Serotonin1B receptor modulation of startle reactivity, habituation, and prepulse inhibition in wild‐type and serotonin1B knockout mice. Psychopharmacology (Berl) 1997, 132:125–134.
30 Chou‐Green, JM, Holscher, TD, Dallman, MF, Akana, SF. Repeated stress in young and old 5‐HT(2C) receptor knockout mice. Physiol Behav 2003, 79:217–226.
31 Nonogaki, K, Abdallah, L, Goulding, EH, Bonasera, SJ, Tecott, LH. Hyperactivity and reduced energy cost of physical activity in serotonin 5‐HT(2C) receptor mutant mice. Diabetes 2003, 52:315–320.
32 Kelley, SP, Bratt, AM, Hodge, CW. Targeted gene deletion of the 5‐HT3A receptor subunit produces an anxiolytic phenotype in mice. Eur J Pharmacol 2003, 461:19–25.
33 Grailhe, R, Waeber, C, Dulawa, SC, Hornung, JP, Zhuang, X, Brunner, D, Geyer, MA, Hen, R. Increased exploratory activity and altered response to LSD in mice lacking the 5‐HT(5A) receptor. Neuron 1999, 22:581–591.
34 Bonasera, SJ, Chu, HM, Brennan, TJ, Tecott, LH. A mutation of the serotonin 6 receptor alters acute responses to ethanol. Neuropsychopharmacology 2006, 31:1801–1813.
35 Hedlund, PB, Danielson, PE, Thomas, EA, Slanina, K, Carson, MJ, Sutcliffe, JG. No hypothermic response to serotonin in 5‐HT7 receptor knockout mice. Proc Natl Acad Sci U S A 2003, 100:1375–1380.
36 Czyrak, A, Czepiel, K, Mackowiak, M, Chocyk, A, Wedzony, K. Serotonin 5‐HT1A receptors might control the output of cortical glutamatergic neurons in rat cingulate cortex. Brain Res 2003, 989:42–51.
37 Amargos‐Bosch, M, Bortolozzi, A, Puig, MV, Serrats, J, Adell, A, Celada, P, Toth, M, Mengod, G, Artigas, F. Co‐expression and in vivo interaction of serotonin1A and serotonin2A receptors in pyramidal neurons of prefrontal cortex. Cereb Cortex 2004, 14:281–299.
38 Santana, N, Bortolozzi, A, Serrats, J, Mengod, G, Artigas, F. Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex. Cereb Cortex 2004, 14: 1100–1109.
39 Celada, P, Puig, MV, Casanovas, JM, Guillazo, G, Artigas, F. Control of dorsal raphe serotonergic neurons by the medial prefrontal cortex: Involvement of serotonin‐1A, GABA(A), and glutamate receptors. J Neurosci 2001, 21:9917–9929.
40 Artigas, F. The prefrontal cortex: a target for antipsychotic drugs. Acta Psychiatr Scand 2010, 121:11–21.
41 Wedzony, K, Chocyk, A, Mackowiak, M. A search for colocalization of serotonin 5‐HT2A and 5‐HT1A receptors in the rat medial prefrontal and entorhinal cortices—immunohistochemical studies. J Physiol Pharmacol 2008, 59:229–238.
42 de Groote, L, Olivier, B, Westenberg, HG. Extracellular serotonin in the prefrontal cortex is limited through terminal 5‐HT(1B) autoreceptors: a microdialysis study in knockout mice. Psychopharmacology (Berl) 2002, 162:419–424.
43 Compan, V, Segu, L, Buhot, MC, Daszuta, A. Differential effects of serotonin (5‐HT) lesions and synthesis blockade on neuropeptide‐Y immunoreactivity and 5‐HT1A, 5‐HT1B/1D and 5‐HT2A/2C receptor binding sites in the rat cerebral cortex. Brain Res 1998, 795:264–276.
44 Cornea‐Hebert, V, Riad, M, Wu, C, Singh, SK, Descarries, L. Cellular and subcellular distribution of the serotonin 5‐HT2A receptor in the central nervous system of adult rat. J Comp Neurol 1999, 409:187–209.
45 Miner, LA, Backstrom, JR, Sanders‐Bush, E, Sesack, SR. Ultrastructural localization of serotonin2A receptors in the middle layers of the rat prelimbic prefrontal cortex. Neuroscience 2003, 116:107–117.
46 Liu, S, Bubar, MJ, Lanfranco, MF, Hillman, GR, Cunningham, KA. Serotonin2C receptor localization in GABA neurons of the rat medial prefrontal cortex: implications for understanding the neurobiology of addiction. Neuroscience 2007, 146:1677–1688.
47 Waeber, C, Sebben, M, Nieoullon, A, Bockaert, J, Dumuis, A. Regional distribution and ontogeny of 5‐HT4 binding sites in rodent brain. Neuropharmacology 1994, 33:527–541.
48 Compan, V, Daszuta, A, Salin, P, Sebben, M, Bockaert, J, Dumuis, A. Lesion study of the distribution of serotonin 5‐HT4 receptors in rat basal ganglia and hippocampus. Eur J Neurosci 1996, 8:2591–2598.
49 Lucas, G, Debonnel, G. 5‐HT4 receptors exert a frequency‐related facilitatory control on dorsal raphe nucleus 5‐HT neuronal activity. Eur J Neurosci 2002, 16:817–822.
50 Lucas, G, et al. Frontocortical 5‐HT4 receptors exert positive feedback on serotonergic activity: viral transfections, subacute and chronic treatments with 5‐HT4 agonists. Biol Psychiatry 2005, 57:918–925.
51 Compan, V, Segu, L, Buhot, MC, Daszuta, A. Selective increases in serotonin 5‐HT1B/1D and 5‐HT2A/2C binding sites in adult rat basal ganglia following lesions of serotonergic neurons. Brain Res 1998, 793: 103–111.
52 Lopez‐Gimenez, JF, Tecott, LH, Palacios, JM, Mengod, G, Vilaro, MT. Serotonin 5‐HT (2C) receptor knockout mice: autoradiographic analysis of multiple serotonin receptors. J Neurosci Res 2002, 67:69–85.
53 Hamon, M, Doucet, E, Lefevre, K, Miquel, MC, Lanfumey, L, Insausti, R, Frechilla, D, Del Rio, J, Verge, D. Antibodies and antisense oligonucleotide for probing the distribution and putative functions of central 5‐HT6 receptors. Neuropsychopharmacology 1999, 21: 68S–76S.
54 Heisler, LK, Jobst, EE, Sutton, GM, Zhou, L, Borok, E, Thornton‐Jones, Z, Liu, HY, Zigman, JM, Balthasar, N, Kishi, T, et al. Serotonin reciprocally regulates melanocortin neurons to modulate food intake. Neuron 2006, 51:239–249.
55 Abramowski, D, Rigo, M, Duc, D, Hoyer, D, Staufenbiel, M. Localization of the 5‐hydroxytryptamine2C receptor protein in human and rat brain using specific antisera. Neuropharmacology 1995, 34:1635–1645.
56 Xu, Y, Jones, JE, Kohno, D, Williams, KW, Lee, CE, Choi, MJ, Anderson, JG, Heisler, LK, Zigman, JM, Lowell, BB, et al. 5‐HT2CRs expressed by pro‐opiomelanocortin neurons regulate energy homeostasis. Neuron 2008, 60:582–589.
57 Gustafson, EL, Durkin, MM, Bard, JA, Zgombick, J, Branchek, TA. A receptor autoradiographic and in situ hybridization analysis of the distribution of the 5‐ht7 receptor in rat brain. Br J Pharmacol 1996, 117: 657–666.
58 Clement, Y, Kia, KH, Daval, G, Verge, D. An autoradiographic study of serotonergic receptors in a murine genetic model of anxiety‐related behaviors. Brain Res 1996, 709:229–242.
59 Aznar, S, Qian, Z, Shah, R, Rahbek, B, Knudsen, GM. The 5‐HT1A serotonin receptor is located on calbindin‐ and parvalbumin‐containing neurons in the rat brain. Brain Res 2003, 959:58–67.
60 Xu, T, Pandey, SC. Cellular localization of serotonin(2A) (5HT(2A)) receptors in the rat brain. Brain Res Bull 2000, 51:499–505.
61 Schechter, LE, Lin, Q, Smith, DL, Zhang, G, Shan, Q, Platt, B, Brandt, MR, Dawson, LA, Cole, D, Bernotas, R, et al. Neuropharmacological profile of novel and selective 5‐HT6 receptor agonists: WAY‐181187 and WAY‐208466. Neuropsychopharmacology 2008, 33:1323–1335.
62 Pompeiano, M, Palacios, JM, Mengod, G. Distribution and cellular localization of mRNA coding for 5‐HT1A receptor in the rat brain: correlation with receptor binding. J Neurosci 1992, 12:440–453.
63 Miquel, MC, Doucet, E, Riad, M, Adrien, J, Verge, D, Hamon, M. Effect of the selective lesion of serotoninergic neurons on the regional distribution of 5‐HT1A receptor mRNA in the rat brain. Brain Res Mol Brain Res 1992, 14:357–362.
64 Riad, M, et al. Somatodendritic localization of 5‐HT1A and preterminal axonal localization of 5‐HT1B serotonin receptors in adult rat brain. J Comp Neurol 2000, 417:181–194.
65 Doucet, E, Pohl, M, Fattaccini, CM, Adrien, J, Mestikawy, SE, Hamon, M. In situ hybridization evidence for the synthesis of 5‐HT1B receptor in serotoninergic neurons of anterior raphe nuclei in the rat brain. Synapse 1995, 19:18–28.
66 Bonaventure, P, Guo, H, Tian, B, Liu, X, Bittner, A, Roland, B, Salunga, R, Ma, XJ, Kamme, F, Meurers, B, et al. Nuclei and subnuclei gene expression profiling in mammalian brain. Brain Res 2002, 943:38–47.
67 Launay, JM, Schneider, B, Loric, S, Da Prada, M, Kellermann, O. Serotonin transport and serotonin transporter‐mediated antidepressant recognition are controlled by 5‐HT2B receptor signaling in serotonergic neuronal cells. FASEB J 2006, 20:1843–1854.
68 Serrats, J, Mengod, G, Cortes, R. Expression of serotonin 5‐HT2C receptors in GABAergic cells of the anterior raphe nuclei. J Chem Neuroanat 2005, 29: 83–91.
69 Clemett, DA, Punhani, T, Duxon, MS, Blackburn, TP, Fone, KC. Immunohistochemical localisation of the 5‐HT2C receptor protein in the rat CNS. Neuropharmacology 2000, 39:123–132.
70 Oliver, KR, Kinsey, AM, Wainwright, A, Sirinathsinghji, DJ. Localization of 5‐ht(5A) receptor‐like immunoreactivity in the rat brain. Brain Res 2000, 867:131–142.
71 Heal, DJ, Smith, SL, Fisas, A, Codony, X, Buschmann, H. Selective 5‐HT6 receptor ligands: progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders. Pharmacol Ther 2008, 117:207–231.
72 Bruce, KR, Steiger, H, Joober, R, Ng Ying Kin, NM, Israel, M, Young, SN. Association of the promoter polymorphism ‐1438G/A of the 5‐HT2A receptor gene with behavioral impulsiveness and serotonin function in women with bulimia nervosa. Am J Med Genet B Neuropsychiatr Genet 2005, 137:40–44.
73 Gorwood, P, Adès, J, Bellodi, L, Cellini, E, Collier, DA, Di Bella, D, Di Bernardo, M, Estivill, X, Fernandez‐Aranda, F, Gratacos, M, et al. The 5‐HT(2A) ‐1438G/A polymorphism in anorexia nervosa: a combined analysis of 316 trios from six European centres. Mol Psychiatry 2002, 7:90–94.
74 Karwautz, A, Rabe‐Hesketh, S, Hu, X, Zhao, J, Sham, P, Collier, DA, Treasure, JL. Individual‐specific risk factors for anorexia nervosa: a pilot study using a discordant sister‐pair design. Psychol Med 2001, 31: 317–329.
75 Nacmias, B, Ricca, V, Tedde, A, Mezzani, B, Rotella, CM, Sorbi, S. 5‐HT2A receptor gene polymorphisms in anorexia nervosa and bulimia nervosa. Neurosci Lett 1999, 277:134–136.
76 Nishiguchi, N, Matsushita, S, Suzuki, K, Murayama, M, Shirakawa, O, Higuchi, S. Association between 5HT2A receptor gene promoter region polymorphism and eating disorders in Japanese patients. Biol Psychiatry 2001, 50:123–128.
77 Ricca, V, Nacmias, B, Cellini, E, Di Bernardo, M, Rotella, CM, Sorbi, S. 5‐HT2A receptor gene polymorphism and eating disorders. Neurosci Lett 2002, 323: 105–108.
78 Ziegler, A, Hebebrand, J, Gorg, T, Rosenkranz, K, Fichter, M, Herpertz‐Dahlmann, B, Remschmidt, H, Hinney, A. Further lack of association between the 5‐HT2A gene promoter polymorphism and susceptibility to eating disorders and a meta‐analysis pertaining to anorexia nervosa. Mol Psychiatry 1999, 4:410–412.
79 Martaskova, D, Slachtova, L, Kemlink, D, Zahorakova, D, Papezova, H. Polymorphisms in serotonin‐related genes in anorexia nervosa. The first study in Czech population and metaanalyses with previously performed studies. Folia Biol (Praha) 2009, 55:192–197.
80 Aubert, R, Betoulle, D, Herbeth, B, Siest, G, Fumeron, F. 5‐HT2A receptor gene polymorphism is associated with food and alcohol intake in obese people. Int J Obes Relat Metab Disord 2000, 24:920–924.
81 Burnet, PW, Smith, KA, Cowen, PJ, Fairburn, CG, Harrison, PJ. Allelic variation of the 5‐HT2C receptor (HTR2C) in bulimia nervosa and binge eating disorder. Psychiatr Genet 1999, 9:101–104.
82 Kishore, S, Stamm, S. The snoRNA HBII‐52 regulates alternative splicing of the serotonin receptor 2C. Science 2006, 311:230–232.
83 Lentes, KU, Hinney, A, Ziegler, A, Rosenkranz, K, Wurmser, H, Barth, N, Jacob, K, Coners, H, Mayer, H, Grzeschik, KH, et al. Evaluation of a Cys23Ser mutation within the human 5‐HT2C receptor gene: no evidence for an association of the mutant allele with obesity or underweight in children, adolescents and young adults. Life Sci 1997, 61:PL9–PL16.
84 McCarthy, S, Mottagui‐Tabar, S, Mizuno, Y, Sennblad, B, Hoffstedt, J, Arner, P, Wahlestedt, C, Andersson, B. Complex HTR2C linkage disequilibrium and promoter associations with body mass index and serum leptin. Hum Genet 2005, 117:545–557.
85 Pooley, EC, Fairburn, CG, Cooper, Z, Sodhi, MS, Cowen, PJ, Harrison, PJ. A 5‐HT2C receptor promoter polymorphism (HTR2C ‐ 759C/T) is associated with obesity in women, and with resistance to weight loss in heterozygotes. Am J Med Genet B Neuropsychiatr Genet 2004, 126:124–127.
86 Reynolds, GP, Zhang, Z, Zhang, X. Polymorphism of the promoter region of the serotonin 5‐HT(2C) receptor gene and clozapine‐induced weight gain. Am J Psychiatry 2003, 160:677–679.
87 Reynolds, GP, Zhang, ZJ, Zhang, XB. Association of antipsychotic drug‐induced weight gain with a 5‐HT2C receptor gene polymorphism. Lancet 2002, 359:2086–2087.
88 Yuan, X, Yamada, K, Ishiyama‐Shigemoto, S, Koyama, W, Nonaka, K. Identification of polymorphic loci in the promoter region of the serotonin 5‐HT2C receptor gene and their association with obesity and type II diabetes. Diabetologia 2000, 43:373–376.
89 Westberg, L, Bah, J, Rastam, M, Gillberg, C, Wentz, E, Melke, J, Hellstrand, M, Eriksson, E. Association between a polymorphism of the 5‐HT2C receptor and weight loss in teenage girls. Neuropsychopharmacology 2002, 26:789–793.
90 Miller del, D, Ellingrod, VL, Holman, TL, Buckley, PF, Arndt, S. Clozapine‐induced weight gain associated with the 5HT2C receptor ‐759C/T polymorphism. Am J Med Genet B Neuropsychiatr Genet 2005, 133: 97–100.
91 Sanders‐Bush, E, Fentress, H, Hazelwood, L. Serotonin 5‐ht2 receptors: molecular and genomic diversity. Mol Interv 2003, 3:319–330.
92 Hinney, A, Herrmann, H, Lohr, T, Rosenkranz, K, Ziegler, A, Lehmkuhl, G, Poustka, F, Schmidt, MH, Mayer, H, Siegfried, W, et al. No evidence for an involvement of alleles of polymorphisms in the serotonin1Dβ
and 7 receptor genes in obesity, underweight or anorexia nervosa. Int J Obes Relat Metab Disord 1999, 23:760–763.
93 Levitan, RD, Kaplan, AS, Masellis, M, Basile, VS, Walker, ML, Lipson, N, Siegel, GI, Woodside, DB, Macciardi, FM, Kennedy, SH. Polymorphism of the serotonin 5‐HT1B receptor gene (HTR1B) associated with minimum lifetime body mass index in women with bulimia nervosa. Biol Psychiatry 2001, 50:640–643.
94 Levitan, RD, Kaplan, AS, Masellis, M, Basile, VS, Richter, MA, Kennedy, JL. The serotonin‐1Dβ
receptor gene and severity of obsessive‐compulsive disorder in women with bulimia nervosa. Eur Neuropsychopharmacol 2006, 16:1–6.
95 Lim, SW, Ha, J, Shin, DW, Woo, HY, Kim, KH. Associations between the serotonin‐1A receptor C(‐1019)G polymorphism and disordered eating symptoms in female adolescents. J Neural Transm 2010, 117:773–779.
96 Boutrel, B, Franc, B, Hen, R, Hamon, M, Adrien, J. Key role of 5‐HT1B receptors in the regulation of paradoxical sleep as evidenced in 5‐HT1B knock‐out mice. J Neurosci 1999, 19:3204–3212.
97 Grignaschi, G, Mantelli, B, Samanin, R. The hypophagic effect of restraint stress in rats can be mediated by 5‐HT2 receptors in the paraventricular nucleus of the hypothalamus. Neurosci Lett 1993, 152:103–106.
98 Compan, V, Charnay, Y, Dusticier, N, Daszuta, A, Hen, R, Bockaert, J. Feeding disorders in 5‐HT4 receptor knockout mice. J Soc Biol 2004, 198:37–49.
99 Ase, AR, Reader, TA, Hen, R, Riad, M, Descarries, L. Altered serotonin and dopamine metabolism in the CNS of serotonin 5‐HT(1A) or 5‐HT(1B) receptor knockout mice. J Neurochem 2000, 75:2415–2426.
100 Ase, AR, Reader, TA, Hen, R, Riad, M, Descarries, L. Regional changes in density of serotonin transporter in the brain of 5‐HT1A and 5‐HT1B knockout mice, and of serotonin innervation in the 5‐HT1B knockout. J Neurochem 2001, 78:619–630.
101 Bortolozzi, A, Amargos‐Bosch, M, Toth, M, Artigas, F, Adell, A. In vivo efflux of serotonin in the dorsal raphe nucleus of 5‐HT1A receptor knockout mice. J Neurochem 2004, 88:1373–1379.
102 Clifton, PG, Lee, MD, Somerville, EM, Kennett, GA, Dourish, CT. 5‐HT1B receptor knockout mice show a compensatory reduction in 5‐HT2C receptor function. Eur J Neurosci 2003, 17:185–190.
103 Jean, A, Laurent, L, Malapris, C, Bockaert, J, Charnay, Y, Dusticier, N, Nieoullon, A, Barrot, M, Neve, R, Compan, V. The 5‐HTR4‐CART pathway in the nucleus accumbens ties anorexia to hyperactivity. In preparation.
104 Evrard, A, Laporte, AM, Chastanet, M, Hen, R, Hamon, M, Adrien, J. 5‐HT1A and 5‐HT1B receptors control the firing of serotoninergic neurons in the dorsal raphe nucleus of the mouse: studies in 5‐HT1B knock‐out mice. Eur J Neurosci 1999, 11:3823–3831.
105 Lee, MD, Somerville, EM, Kennett, GA, Dourish, CT, Clifton, PG. Reduced hypophagic effects of d‐fenfluramine and the 5‐HT2C receptor agonist mCPP in 5‐HT1B receptor knockout mice. Psychopharmacology (Berl) 2004, 176:39–49.
106 Richer, M, Hen, R, Blier, P. Modification of serotonin neuron properties in mice lacking 5‐HT1A receptors. Eur J Pharmacol 2002, 435:195–203.
107 Barthet, G, Gaven, F, Framery, B, Shinjo, K, Nakamura, T, Claeysen, S, Bockaert, J, Dumuis, A. Uncoupling and endocytosis of 5‐hydroxytryptamine 4 receptors. Distinct molecular events with different GRK2 requirements. J Biol Chem 2005, 280:27924–27934.
108 Ansanay, H, Dumuis, A, Sebben, M, Bockaert, J, Fagni, L. cAMP‐dependent, long‐lasting inhibition of a K+ current in mammalian neurons. Proc Natl Acad Sci U S A 1995, 92:6635–6639.
109 Cai, X, Flores‐Hernandez, J, Feng, J, Yan, Z. Activity‐dependent bidirectional regulation of GABA(A) receptor channels by the 5‐HT(4) receptor‐mediated signalling in rat prefrontal cortical pyramidal neurons. J Physiol 2002, 540:743–759.
110 Fagni, L, Dumuis, A, Sebben, M, Bockaert, J. The 5‐HT4 receptor subtype inhibits K+ current in colliculi neurones via activation of a cyclic AMP‐dependent protein kinase. Br J Pharmacol 1992, 105:973–979.
111 Bickmeyer, U, Heine, M, Manzke, T, Richter, DW. Differential modulation of I(h) by 5‐HT receptors in mouse CA1 hippocampal neurons. Eur J Neurosci 2002, 16:209–218.
112 Bockaert, J, Claeysen, S, Compan, V, Dumuis, A. 5‐HT(4) receptors: history, molecular pharmacology and brain functions. Neuropharmacology 2008, 55:922–931.
113 Barthet, G, Carrat, G, Cassier, E, Barker, B, Gaven, F, Pillot, M, Framery, B, Pellissier, LP, Augier, J, Kang, DS, et al. β
‐Arrestin1 phosphorylation by GRK5 regulates G protein‐independent 5‐HT4 receptor signalling. EMBO J 2009, 28:2706–2718.
114 Lezoualc`h, F, Robert, SJ. The serotonin 5‐HT4 receptor and the amyloid precursor protein processing. Exp Gerontol 2003, 38:159–166.
115 Barthet, G, Framery, B, Gaven, F, Pellissier, L, Reiter, E, Claeysen, S, Bockaert, J, Dumuis, A. 5‐Hydroxytryptamine 4 receptor activation of the extracellular signal‐regulated kinase pathway depends on Src activation but not on G protein or β
‐arrestin signaling. Mol Biol Cell 2007, 18:1979–1991.
116 Gill, RK, Saksena, S, Tyagi, S, Alrefai, WA, Malakooti, J, Sarwar, Z, Turner, JR, Ramaswamy, K, Dudeja, PK. Serotonin inhibits Na+/H+ exchange activity via 5‐HT4 receptors and activation of PKC α
in human intestinal epithelial cells. Gastroenterology 2005, 128:962–974.
117 Heisler, LK, Cowley, MA, Tecott, LH, Fan, W, Low, MJ, Smart, JL, Rubinstein, M, Tatro, JB, Marcus, JN, Holstege, H, et al. Activation of central melanocortin pathways by fenfluramine. Science 2002, 297:609–611.
118 Kennett, GA, Curzon, G. Evidence that hypophagia induced by mCPP and TFMPP requires 5‐HT1C and 5‐HT1B receptors; hypophagia induced by RU 24969 only requires 5‐HT1B receptors. Psychopharmacology (Berl) 1988, 96:93–100.
119 Klodzinska, A, Chojnacka‐Wojcik, E. Anorexia induced by M‐trifluoromethylphenylpiperazine (TFMPP) in rats. Pol J Pharmacol Pharm 1990, 42:13–17.
120 Yadav, VK, Oury, F, Suda, N, Liu, ZW, Gao, XB, Confavreux, C, Klemenhagen, KC, Tanaka, KF, Gingrich, JA, Guo, XE, et al. A serotonin‐dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure. Cell 2009, 138:976–989.
121 Aulakh, CS, Hill, JL, Murphy, DL. A comparison of feeding and locomotion responses to serotonin agonists in three rat strains. Pharmacol Biochem Behav 1988, 31:567–571.
122 Bendotti, C, Samanin, R. The role of putative 5‐HT1A and 5‐HT1B receptors in the control of feeding in rats. Life Sci 1987, 41:635–642.
123 Casanovas, JM, Berton, O, Celada, P, Artigas, F. In vivo actions of the selective 5‐HT1A receptor agonist BAY x 3702 on serotonergic cell firing and release. Naunyn Schmiedebergs Arch Pharmacol 2000, 362:248–254.
124 Casanovas, JM, Lesourd, M, Artigas, F. The effect of the selective 5‐HT1A agonists alnespirone (S‐20499) and 8‐OH‐DPAT on extracellular 5‐hydroxytryptamine in different regions of rat brain. Br J Pharmacol 1997, 122:733–741.
125 Haj‐Dahmane, S, Hamon, M, Lanfumey, L. K+ channel and 5‐hydroxytryptamine1A autoreceptor interactions in the rat dorsal raphe nucleus: an in vitro electrophysiological study. Neuroscience 1991, 41:495–505.
126 Le Poul, E, Lima, L, Laporte, AM, Even, C, Doucet, E, Fattaccini, CM, Laaris, N, Hamon, M, Lanfumey, L. Central serotonin receptors and chronic treatment with selective serotonin reuptake inhibitors in the rat: comparative effects of fluoxetine and paroxetine. Encephale 1995, 21:123–132.
127 Sprouse, JS, Aghajanian, GK. Electrophysiological responses of serotoninergic dorsal raphe neurons to 5‐HT1A and 5‐HT1B agonists. Synapse 1987, 1:3–9.
128 Bendotti, C, Samanin, R. 8‐Hydroxy‐2‐(di‐n‐propylamino) tetralin (8‐OH‐DPAT) elicits eating in free‐feeding rats by acting on central serotonin neurons. Eur J Pharmacol 1986, 121:147–150.
129 Dourish, CT, Hutson, PH, Kennett, GA, Curzon, G. 8‐OH‐DPAT‐induced hyperphagia: its neural basis and possible therapeutic relevance. Appetite 1986, 7(Suppl):127–140.
130 Hutson, PH, Dourish, CT, Curzon, G. Evidence that the hyperphagic response to 8‐OH‐DPAT is mediated by 5‐HT1A receptors. Eur J Pharmacol 1988, 150:361–366.
131 Shepherd, JK, Rodgers, RJ. 8‐OH‐DPAT specifically enhances feeding behaviour in mice: evidence from behavioural competition. Psychopharmacology (Berl) 1990, 101:408–413.
132 Hartley, JE, Fletcher, A. The effects of WAY‐100135 and 8‐hydroxy‐2‐(di‐n‐propylamino)tetralin on feeding in the rat. Eur J Pharmacol 1994, 252:329–332.
133 Grignaschi, G, Invernizzi, RW, Fanelli, E, Fracasso, C, Caccia, S, Samanin, R. Citalopram‐induced hypophagia is enhanced by blockade of 5‐HT(1A) receptors: role of 5‐HT(2C) receptors. Br J Pharmacol 1998, 124:1781–1787.
134 Kennett, GA, Ainsworth, K, Trail, B, Blackburn, TP. BW 723C86, a 5‐HT2B receptor agonist, causes hyperphagia and reduced grooming in rats. Neuropharmacology 1997, 36:233–239.
135 Vickers, SP, Dourish, CT, Kennett, GA. Evidence that hypophagia induced by d‐fenfluramine and d‐norfenfluramine in the rat is mediated by 5‐HT2C receptors. Neuropharmacology 2001, 41:200–209.
136 Lawton, CL, Blundell, JE. 5‐HT manipulation and dietary choice: variable carbohydrate (Polycose) suppression demonstrated only under specific experimental conditions. Psychopharmacology (Berl) 1993, 112:375–382.
137 Yamada, J, Sugimoto, Y, Yoshikawa, T, Noma, T, Horisaka, K. The effects of peripheral serotonin2 receptor agonist on food intake of rats. Adv Exp Med Biol 1996, 398:555–557.
138 De Vry, J, Schreiber, R. Effects of selected serotonin 5‐HT(1) and 5‐HT(2) receptor agonists on feeding behavior: possible mechanisms of action. Neurosci Biobehav Rev 2000, 24:341–353.
139 Takeda, H, et al. Rikkunshito, an herbal medicine, suppresses cisplatin‐induced anorexia in rats via 5‐HT2 receptor antagonism. Gastroenterology 2008, 134:2004–2013.
140 Thomsen, WJ, Grottick, AJ, Menzaghi, F, Reyes‐Saldana, H, Espitia, S, Yuskin, D, Whelan, K, Martin, M, Morgan, M, Chen, W, et al. Lorcaserin, a novel selective human 5‐hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization. J Pharmacol Exp Ther 2008, 325:577–587.
141 Bonhaus, DW, Weinhardt, KK, Taylor, M, DeSouza, A, McNeeley, PM, Szczepanski, K, Fontana, DJ, Trinh, J, Rocha, CL, Dawson, MW, et al. RS‐102221: a novel high affinity and selective, 5‐HT2C receptor antagonist. Neuropharmacology 1997, 36:621–629.
142 Mazzola‐Pomietto, P, Aulakh, CS, Murphy, DL. Temperature, food intake, and locomotor activity effects of a 5‐HT3 receptor agonist and two 5‐HT3 receptor antagonists in rats. Psychopharmacology (Berl) 1995, 121:488–493.
143 Pal, GK, Kannan, N, Pal, P. Effects of injection of serotonin into nucleus caudatus on food and water intake and body weight in albino rats. Indian J Physiol Pharmacol 2004, 48:437–445.
144 Fisas, A, Codony, X, Romero, G, Dordal, A, Giraldo, J, Merce, R, Holenz, J, Vrang, N, Sorensen, RV, Heal, D, et al. Chronic 5‐HT6 receptor modulation by E‐6837 induces hypophagia and sustained weight loss in diet‐induced obese rats. Br J Pharmacol 2006, 148:973–983.
145 Halford, JC, Harrold, JA, Boyland, EJ, Lawton, CL, Blundell, JE. Serotonergic drugs : effects on appetite expression and use for the treatment of obesity. Drugs 2007, 67:27–55.
146 Rowland, NE. Neurobiology of an anorectic drug: fenfluramine. Prog Neurobiol 1986, 27:13–62.
147 Przegalinski, E, Jurkowska, T. Effect of repeated treatment with antidepressant drugs or electroconvulsive shock (ECS) on the increase in food intake induced by clonidine injected into the paraventricular nucleus. Arch Int Pharmacodyn Ther 1987, 290:257–266.
148 Luque, CA, Rey, JA. The discovery and status of sibutramine as an anti‐obesity drug. Eur J Pharmacol 2002, 440:119–128.
149 Grignaschi, G, Samanin, R. Role of 5‐HT receptors in the effect of d‐fenfluramine on feeding patterns in the rat. Eur J Pharmacol 1992, 212:287–289.
150 Neill, JC, Cooper, SJ. Evidence that d‐fenfluramine anorexia is mediated by 5‐HT1 receptors. Psychopharmacology (Berl) 1989, 97:213–218.
151 Vickers, SP, Clifton, PG, Dourish, CT. Behavioural evidence that d‐fenfluramine‐induced anorexia in the rat is not mediated by the 5‐HT1A receptor subtype. Psychopharmacology (Berl) 1996, 125:168–175.
152 Ginawi, OT, Al‐Majed, AA, Al‐Suwailem, AK. Ondansetron, a selective 5‐HT3 antagonist, antagonizes methamphetamine‐induced anorexia in mice. Pharmacol Res 2005, 51:255–259.
153 Schwartz, GJ. Brainstem integrative function in the central nervous system control of food intake. Forum Nutr 2010, 63:141–151.
154 Lam, DD, Garfield, AS, Marston, OJ, Shaw, J, Heisler, LK. Brain serotonin system in the coordination of food intake and body weight. Pharmacol Biochem Behav 2010, 97:84–91.
155 Pratt, WE, Blackstone, K. Nucleus accumbens acetylcholine and food intake: decreased muscarinic tone reduces feeding but not food‐seeking. Behav Brain Res 2009, 198:252–257.
156 Bendotti, C, Garattini, S, Samanin, R. Hyperphagia caused by muscimol injection in the nucleus raphe dorsalis of rats: its control by 5‐hydroxytryptamine in the nucleus accumbens. J Pharm Pharmacol 1986, 38:541–543.